IND/NDA Route To U.S. Herbals Market May Need Rethinking - U.S. Attorney
This article was originally published in The Tan Sheet
Executive Summary
European marketers may want to reconsider the risks and costs of using the IND/NDA process to get herbals approved for marketing in the U.S., Washington, D.C. attorney Paul Hyman (Hyman, Phelps & McNamara) suggested at a recent IBC U.K. conference on herbals extract marketing in London.